{
    "SPADE_UN_18875": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18875",
            "Peptide Name": "Api88(1-17) (Synthetic AMPs, Pro-rich, PrAMPs, XXA, UCLL1c; Api88(1-16), inactive)",
            "Source": "Amino acid substitution, insect pro-rich peptide analog, ainmal-derived, natural derivatives",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "KNNRPVYIPRPRPPHPR",
            "Sequence Length": 17,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2094.43,
            "PI": 12.0,
            "Hydrophobicity": -2.02,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Berthold N, Czihal P, Fritsche S, Sauer U, Schiffer G, Knappe D, Alber G, Hoffmann R. 2013",
                    "Reference": "Antimicrob Agents Chemother. 2013 Jan;57(1):402-9. doi: 10.1128/AAC.01923-12.PubMed",
                    "Title": "Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens."
                }
            ],
            "Frequent Amino Acids": "PRN",
            "Absent Amino Acids": "ACDEFGLMOQSTUW",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 10,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "Net Charge": 6,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (94.12%) toApi88P:35%; R: 24%; N: 12%.Chemical modification: N-terminal coupled with N,N,N=,N=-tetramethylguanidino group (Gu); warning: N-terminal ornithine is represented as K; C-terminal amidation. Compared to Api88, the C-terminal residue L was deleted.Activity:  active against E. coli BL21 AI (MIC 64 ug/ml).Half-life in vitro:serum:mouse: half life in  undiluted mouse serum: 152 min.SAR: Further C-terminal delection of R led to inactive Api88(1-16) (MIC > 128 ug/ml).Updated 11/2024",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_18874",
                    "Similarity": 1.0,
                    "Sequence": "KNNRPVYIPRPRPPHPRL"
                },
                {
                    "SPADE_ID": "SPADE_N_08859",
                    "Similarity": 1.0,
                    "Sequence": "NNRPVYIPRPRPPHPRI"
                },
                {
                    "SPADE_ID": "SPADE_N_08863",
                    "Similarity": 1.0,
                    "Sequence": "NNRPVYIPRPRPPHPRPIRV"
                }
            ]
        }
    }
}